Company Overview
LifeStance Health Group, Inc. operates as a provider of outpatient mental health services within the United States, catering to a demographic that spans children, adolescents, adults, and geriatrics. The company functions within the broader Healthcare sector, specifically in the Medical Care Facilities industry, where it delivers a multidisciplinary suite of services including psychiatric evaluations and treatment alongside psychological support. This entity maintains a significant operational scale with a total market capitalization of $2.45B and an annual revenue run-rate of $1.42B based on trailing twelve-month figures. The organization supports this extensive operation through a workforce comprising 10,961 employees, indicating a substantial physical footprint and service delivery network. The market cap figure of $2.45B suggests that the market values the company's asset base and future service potential at a level that reflects its position as a major player in the behavioral health landscape, while the revenue of $1.42B demonstrates a consistent stream of income generated from providing these essential medical care facilities to a wide patient base.
Financial Health
The company reported total revenue of $1.42B for the trailing twelve months, accompanied by a net income of $9.66M and an EBITDA of $79.92M. The substantial disparity between the $1.42B in revenue and the $9.66M in net income reveals a cost structure characterized by significant operating expenses, resulting in a profit margin of merely 0.7%. Despite the thin net profit, the company generated $112.90M in free cash flow, which provides a critical buffer for financial flexibility, allowing for capital expenditures or strategic acquisitions without immediate reliance on external financing. The gross margin stands at 32.4%, indicating that the cost of goods sold consumes a moderate portion of revenue before other expenses are deducted, while the operating margin of 4.7% highlights the efficiency of the company's core operations before interest and taxes. The balance sheet shows a cash position of $248.64M against total debt of $474.52M, resulting in a debt-to-equity ratio of 31.20, which suggests a leveraged balance sheet where debt obligations exceed internal cash reserves. However, the current ratio of 1.65 indicates that the company holds sufficient current assets to cover its short-term liabilities, maintaining adequate liquidity for daily operations. Return on Equity and Return on Assets both stand at 0.7%, metrics that reveal management's current effectiveness in generating returns relative to the shareholders' equity and the total assets employed is currently low, reflecting the high cost structure or asset-heavy nature of the medical care facility model.
Valuation Assessment
Valuation metrics for LifeStance Health Group, Inc. show a trailing P/E ratio of 320.00, which is markedly higher than the forward P/E of 16.74, implying that the market expects a significant expansion in earnings in the coming years to justify the current price. The price-to-book ratio is 1.63, indicating that the stock trades at a premium of 63% over its book value, suggesting investors are paying extra for the company's growth prospects and brand within the healthcare sector. Alternative valuation measures include a price-to-sales ratio of 1.72 and an EV/EBITDA of 34.04, which suggest that the company is valued primarily on its revenue generation capabilities and earnings before interest, taxes, depreciation, and amortization rather than current net income. The stock's recent trading range has fluctuated between a 52-week low of $3.74 and a 52-week high of $8.09, providing a context for assessing the current share price relative to its historical volatility over the past year. The beta value of 1.11 indicates that the stock price is slightly more volatile than the broader market, moving 11% more than the market average during periods of fluctuation, which is consistent with small-to-mid-cap healthcare stocks.
Growth & Income
Revenue growth for the trailing twelve months stands at 17.4%, while earnings growth is listed as N/A due to the low absolute net income figure relative to the revenue base. Since earnings growth data is not available in the provided facts, the analysis cannot confirm whether earnings are growing faster or slower than revenue, but the high revenue growth rate suggests expanding demand for outpatient mental health services. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the company reinvests all its earnings back into the business rather than distributing them to shareholders. This reinvestment strategy is typical for growth-oriented companies in the medical care facilities industry that prioritize scaling operations and expanding their network of 10,961 employees over immediate income distribution. The overall growth and income profile is defined by robust top-line expansion driven by a 17.4% increase in revenue, coupled with a lack of dividend payouts that directs capital toward operational growth and market share acquisition within the competitive mental health services landscape.